GH Research PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GHRS Nasdaq 2834 www.ghres.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GH Research PLC

Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect? - Nov 20th, 2024 2:55 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Nov 18th, 2024 12:19 pm
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates - Nov 14th, 2024 12:00 pm
We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth - Nov 10th, 2024 12:06 pm
GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade - Sep 9th, 2024 4:00 pm
After Plunging -18.19% in 4 Weeks, Here's Why the Trend Might Reverse for GH Research (GHRS) - Sep 9th, 2024 1:35 pm
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates - Sep 3rd, 2024 11:05 am
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - Sep 3rd, 2024 11:00 am
3 Psychedelic Stocks to Ride to the Moon and Beyond - Jul 6th, 2024 11:21 am
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns - Jul 3rd, 2024 1:48 pm
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans - Jun 2nd, 2024 12:33 pm
Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why - May 13th, 2024 12:50 pm
Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know - May 10th, 2024 1:55 pm
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates - May 3rd, 2024 11:00 am
How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28% - Mar 5th, 2024 2:55 pm
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates - Feb 29th, 2024 12:00 pm
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression - Jan 18th, 2024 9:30 pm
Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? - Jan 16th, 2024 2:55 pm
11 Best Psychedelic Stocks to Buy in 2024 - Dec 29th, 2023 1:47 pm
We're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wisely - Dec 25th, 2023 10:10 am